WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1

SIMPLE SUMMARY: Therapeutic options for rare cancers are frequently limited and less effective than for common cancers. Therefore, novel therapeutic strategies to treat rare cancers are urgently required. Our clinical study on rare cancers showed that the biweekly WT1 Trio peptide vaccine comprising...

Descripción completa

Detalles Bibliográficos
Autores principales: Oji, Yusuke, Kagawa, Naoki, Arita, Hideyuki, Naka, Norifumi, Hamada, Ken-ichiro, Outani, Hidetatsu, Shintani, Yasushi, Takeda, Yoshito, Morii, Eiichi, Shimazu, Kenzo, Suzuki, Motoyuki, Nishida, Sumiyuki, Nakata, Jun, Tsuboi, Akihiro, Iwai, Miki, Hayashi, Sae, Imanishi, Rin, Ikejima, Sayaka, Kanegae, Mizuki, Iwamoto, Masahiro, Ikeda, Mayu, Yagi, Kento, Shimokado, Haruka, Nakajima, Hiroko, Hasegawa, Kana, Morimoto, Soyoko, Fujiki, Fumihiro, Nagahara, Akira, Tanemura, Atsushi, Ueda, Yutaka, Mizushima, Tsunekazu, Ohmi, Masato, Ishida, Takayuki, Fujimoto, Manabu, Nonomura, Norio, Kimura, Tadashi, Inohara, Hidenori, Okada, Seiji, Kishima, Haruhiko, Hosen, Naoki, Kumanogoh, Atsushi, Oka, Yoshihiro, Sugiyama, Haruo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857088/
https://www.ncbi.nlm.nih.gov/pubmed/36672344
http://dx.doi.org/10.3390/cancers15020393

Ejemplares similares

Ejemplares similares